<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kennon Heard, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard Dart, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michele M Burns, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael Ganetsky, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H5084915">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since its clinical introduction in 1950,
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         (N-acetyl-p-aminophenol; APAP; paracetamol) has become the most widely used analgesic and antipyretic in the United States. The popularity of acetaminophen among pediatricians increased when concerns were raised about an association between
         <a class="drug drug_pediatric" data-topicid="12829" href="/z/d/drug information/12829.html" rel="external">
          aspirin
         </a>
         and Reye syndrome.
        </p>
        <p>
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          Acetaminophen
         </a>
         is available in hundreds of over-the-counter and prescription medications. Although it is remarkably safe when used at therapeutic doses, acute acetaminophen overdose (defined as any pattern of acetaminophen ingestion as long as the serum concentration can be measured within 24 hours of swallowing the first dose) has been recognized to cause fatal and nonfatal hepatic necrosis since 1966 [
         <a href="#rid1">
          1,2
         </a>
         ]. In addition, repeated supratherapeutic doses can cause hepatotoxicity in children with certain risk factors, including decreased oral intake [
         <a href="#rid3">
          3-5
         </a>
         ].
        </p>
        <p>
         The clinical manifestations and diagnosis of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         poisoning in children and adolescents will be presented here. The evaluation of acetaminophen poisoning in adults and the management of acetaminophen poisoning in children, adolescents, and adults is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/340.html" rel="external">
          "Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5084922">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          Acetaminophen
         </a>
         remains a major cause of overdose in children throughout the world. In the United States, pediatric acetaminophen exposures account for approximately 30,000 reports to the National Poison Data System annually [
         <a href="#rid6">
          6
         </a>
         ]. The outcome of acetaminophen poisoning in children and adolescents is nearly always good if the antidote,
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         , is administered within 8 to 10 hours of ingestion. Mortality is rare in children and adolescents. (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children", section on 'Acetylcysteine administration and monitoring'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5084929">
         <span class="h2">
          Patterns of exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         The potential for toxicity from
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         overdose in children and adolescents largely depends upon the circumstances surrounding the exposure.
        </p>
        <p class="headingAnchor" id="H5084936">
         <span class="h3">
          Intentional
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intentional
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         ingestions are more prevalent among older children and adolescents. These ingestions tend to be single event, high-dose ingestions. The suicidal intent of these ingestions may be disclosed by the child or adolescent after ingestion, or discovered only through toxicologic screening. Children and adolescents who ingest acetaminophen as a suicide gesture may underestimate its toxicity and more frequently develop hepatotoxicity than young children with exploratory ingestions [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1229.html" rel="external">
          "Suicidal behavior in children and adolescents: Epidemiology and risk factors"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6496.html" rel="external">
          "Approach to the child with occult toxic exposure"
         </a>
         .)
        </p>
        <p>
         Intentional poisoning of infants with
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         has been reported in cases of child abuse and is also associated with significant toxicity [
         <a href="#rid8">
          8,9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5084944">
         <span class="h3">
          Unintentional
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unintentional ingestions are more common among younger children. These ingestions may occur through "exploratory" hand to mouth behavior [
         <a href="#rid10">
          10
         </a>
         ] or inappropriate dosing [
         <a href="#rid11">
          11-13
         </a>
         ], even under medical supervision [
         <a href="#rid14">
          14-16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5084951">
         <span class="h4">
          Exploratory
         </span>
         <span class="headingEndMark">
          —
         </span>
         The vast majority of exploratory ingestions (ie, ingestion of unsecured medication by young children) involves small doses and often can be managed without referral to an emergency department [
         <a href="#rid17">
          17,18
         </a>
         ]. Significant morbidity and mortality rarely occur [
         <a href="#rid3">
          3-5,19,20
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5084958">
         <span class="h4">
          Inappropriate dosing by a caregiver
         </span>
         <span class="headingEndMark">
          —
         </span>
         In contrast with exploratory ingestions, inadvertent repeated supratherapeutic overdose of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         in young children is the most frequent cause of severe acetaminophen toxicity or death in this age group [
         <a href="#rid3">
          3-5,19
         </a>
         ]. Diagnosis of these unintentional ingestions due to inappropriate dosing may be delayed, since the symptoms and signs are nonspecific and may mimic those of the acute illness for which acetaminophen was being administered. The history of ingestion is also often difficult to obtain because parents or caregivers may be reluctant to acknowledge that they made an error that contributed to their child's illness. Per manufacturer recommendations, the use of weight to select the best dose is preferred although the use of age is an acceptable alternative.
        </p>
        <p>
         Inappropriate dosing may occur in the following circumstances:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         When adult
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         formulations are administered to children (eg, substitution of 325 or 500 mg tablet for 80 or 160 mg tablet)  (
         <a class="graphic graphic_table graphicRef79854" href="/z/d/graphic/79854.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Through misreading (or unclear) instruction guidelines for liquid preparations (eg, substituting the infant drop formulation [100 mg/mL] for the less concentrated elixir or syrup [32 to 33 mg/mL])  (
         <a class="graphic graphic_table graphicRef79854" href="/z/d/graphic/79854.html" rel="external">
          table 1
         </a>
         ). This type of error has decreased in the United States since the concentrated infant drop formula was discontinued in 2011 [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Through "intentional" overdose, when parents or caregivers perceive that effective therapy has not been achieved with pediatric formulations (eg, 160 mg per 5 mL) in the appropriate dose (10 to 15 mg/kg) and increase the frequency or dosage of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         [
         <a href="#rid4">
          4,5,22
         </a>
         ], or combine acetaminophen with other antipyretics [
         <a href="#rid23">
          23
         </a>
         ], exceeding dose and duration on product labeling.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There are reports suggesting that some conditions may predispose children to liver injury from therapeutic
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         doses. However, many of these reports are of low quality and lack sufficient information for a formal causality assessment [
         <a href="#rid24">
          24
         </a>
         ]. Putative risk factors are starvation, postoperative condition, inborn errors of metabolism and CYP2E1 induction by other medications such as
         <a class="drug drug_pediatric" data-topicid="12767" href="/z/d/drug information/12767.html" rel="external">
          rifampin
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="13393" href="/z/d/drug information/13393.html" rel="external">
          isoniazid
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         By consuming multiple acetaminophen-containing products concurrently (ie, prescription products and nonprescription products or single substance and combination products).
        </p>
        <p>
        </p>
        <p>
         A profile of the child who may be at increased risk for hepatotoxicity from repeated supratherapeutic
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         dosing at home has been derived from case series. Characteristic features include a sick child who is younger than two years of age and is exposed in one of the following ways [
         <a href="#rid5">
          5,11,19,25-27
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dosing that exceeds more than 90 mg/kg per day of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         for more than one day (eg, only 20 percent greater than the maximum recommended daily dose of 75 mg/kg)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Administration of multiple doses of adult-strength preparations
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Administration of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         suppositories
        </p>
        <p>
        </p>
        <p>
         Although hepatoxicity has been reported in a few children who received multiple therapeutic doses of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         [
         <a href="#rid5">
          5
         </a>
         ], the ascertainment of dose through parent or caregiver recall in these cases is questionable. Furthermore, a study of therapeutic dosing in a group of 100 hospitalized children and adolescents who received therapeutic doses of acetaminophen (greater than or equal to six doses of 10 to 15 mg/kg per dose over a 48-hour period) and were at risk for acetaminophen toxicity due to decreased oral intake failed to find any hepatotoxicity attributable to acetaminophen [
         <a href="#rid28">
          28
         </a>
         ]. Thus, the likelihood of toxicity from multiple therapeutic doses of acetaminophen in the majority of children appears low.
        </p>
        <p class="headingAnchor" id="H2978491">
         <span class="h4">
          Iatrogenic intravenous overdose
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intravenous
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         has been available in the United Kingdom since 2003 and was available for use in the United States in 2010 [
         <a href="#rid29">
          29
         </a>
         ]. Tenfold iatrogenic overdoses have been described in hospitalized young children receiving intravenous acetaminophen for pain relief [
         <a href="#rid30">
          30
         </a>
         ]. The typical error occurs when the dose in mg is mistakenly given as the volume in mL. Other errors include human error when determining the volume to infuse by pump, duplicated doses, and intravenous injection of the oral suspension [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
         Treatment is controversial and consultation with a poison control center or medical toxicologist is strongly advised if a child receives a single intravenous
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         dose ≥90 mg/kg actual total body weight (TBW) or a cumulative dose ≥150 mg/kg TBW during 24 hours [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children", section on 'Patient with Iatrogenic intravenous overdose'
         </a>
         and
         <a class="local">
          'Additional resources'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H5084965">
         <span class="h1">
          PHARMACOKINETICS AND TOXICOKINETICS
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          Acetaminophen
         </a>
         (paracetamol) is available in a variety of oral formulations, rectal suppositories, and an intravenous preparation. Toxicity, consisting primarily of hepatotoxicity, occurs when a large portion of the toxic, highly reactive, electrophilic intermediated, N-acetyl-p-benzoquinoneimine is produced after acetaminophen overdose. (See
         <a class="medical medical_review" href="/z/d/html/340.html" rel="external">
          "Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and evaluation", section on 'Biochemical toxicity'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          Acetaminophen
         </a>
         is rapidly and completely absorbed from the gastrointestinal tract, with peak serum concentrations reached from one-half to two hours after a therapeutic oral dose [
         <a href="#rid31">
          31
         </a>
         ]. Peak serum concentrations are reached within four hours in most cases of overdose of immediate-release preparations. However, following high-risk overdose (&gt;30 grams), overdose of extended-release preparations [
         <a href="#rid32">
          32-34
         </a>
         ] or with co-ingestions that delay gastric emptying [
         <a href="#rid35">
          35
         </a>
         ], peak serum concentrations may be delayed beyond four hours. The various suppository preparations have different absorption characteristics and reach peak concentration at variable times [
         <a href="#rid36">
          36-38
         </a>
         ].
        </p>
        <p>
         Elimination half-lives range from two to four hours for all
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         preparations. However, elimination may appear to be prolonged for extended-release preparations because of prolonged tablet dissolution and absorption [
         <a href="#rid33">
          33,39
         </a>
         ]. Elimination is delayed in cases with hepatotoxicity; serum half-lives greater than four hours are considered a marker of poor prognosis [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/340.html" rel="external">
          "Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and evaluation"
         </a>
         .)
        </p>
        <p>
         The metabolism of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         at therapeutic  (
         <a class="graphic graphic_figure graphicRef68213" href="/z/d/graphic/68213.html" rel="external">
          figure 1
         </a>
         ) and toxic doses is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/340.html" rel="external">
          "Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and evaluation", section on 'Biochemical toxicity'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5084972">
         <span class="h2">
          Risk factors in children
         </span>
         <span class="headingEndMark">
          —
         </span>
         Liver damage caused by excess N-acetyl-p-benzoquinoneimine (NAPQI) can occur in four circumstances  (
         <a class="graphic graphic_figure graphicRef68213" href="/z/d/graphic/68213.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid41">
          41-45
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Excessive intake of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased capacity for glucuronidation or sulfation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased cytochrome P450 (CYP2E1) activity
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depletion of glutathione stores
        </p>
        <p>
        </p>
        <p>
         A number of risk factors may influence the propensity of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         to cause hepatotoxicity in children through the mechanisms listed above, including patient age, pattern of ingestion, nutritional status, concomitant use of CYP2E1-inducing drugs, comorbid illnesses, and genetic background [
         <a href="#rid3">
          3,46
         </a>
         ]. These factors, summarized briefly below, are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/340.html" rel="external">
          "Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and evaluation", section on 'Clinical factors that may influence toxicity'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Age
         </strong>
         –
         <strong>
         </strong>
         Following acute overdose, children younger than six years of age appear to be less susceptible to hepatotoxicity than older children and adults [
         <a href="#rid47">
          47-52
         </a>
         ]. The reasons for this are unclear, but several hypotheses have been proposed:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Compared with adults, infants and young children are believed to have greater capacity for conjugation with sulfate [
         <a href="#rid49">
          49,51,53
         </a>
         ]. Adult patterns of metabolism are reached between 10 and 12 years of age [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Young children are likely protected by an increased supply and regeneration of glutathione [
         <a href="#rid51">
          51,54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Young children have a greater propensity to vomit after
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         ingestion [
         <a href="#rid49">
          49,52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Repeated excessive dosing
         </strong>
         – In both children and adults, repeated administration of supratherapeutic doses is associated with greater morbidity and mortality than an acute overdose [
         <a href="#rid4">
          4,55
         </a>
         ]. Repeated supratherapeutic dosing is often associated with other risk factors for hepatotoxicity, such as fasting or delayed presentation. (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children", section on 'Inappropriate therapeutic dosing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nutritional status
         </strong>
         – Fasting or malnutrition depletes hepatic stores of glucuronide and/or glutathione, leading to increased microsomal metabolism of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         and accumulation of free NAPQI, respectively, predisposing to hepatic injury  (
         <a class="graphic graphic_figure graphicRef68213" href="/z/d/graphic/68213.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid56">
          56-62
         </a>
         ]. Patients at greatest risk appear to be those who consume multiple excessive doses rather than an acute overdose. This scenario is common among children suffering from an acute febrile illness, who may receive multiple doses or prolonged duration of acetaminophen.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Comorbidities
         </strong>
         – Intercurrent or febrile illness appears to predispose some children to hepatotoxicity after multiple supratherapeutic doses [
         <a href="#rid63">
          63,64
         </a>
         ]. The mechanism is not clear. It is speculated that intercurrent or febrile illnesses lower the threshold for hepatic injury, alter the clearance of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         [
         <a href="#rid63">
          63
         </a>
         ], or are associated with other risk factors for hepatotoxicity (eg, decreased oral intake) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with Gilbert syndrome may be predisposed to hepatotoxicity because of impaired glucuronidation [
         <a href="#rid65">
          65,66
         </a>
         ]. However, studies are not consistent and at least one study reports that the pattern of metabolites in urine of patients with Gilbert syndrome is similar to normal subjects [
         <a href="#rid67">
          67
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3578.html" rel="external">
          "Gilbert syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with chronic liver disease usually have low cytochrome oxidase enzyme activity, which may be protective following
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         overdose, even though the elimination half-life may be prolonged [
         <a href="#rid68">
          68,69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Medications and co-ingestants
         </strong>
         – Concomitant use of agents that induce CYP2E1 enzymes can cause hepatotoxicity in the absence of overt
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         overdose and may worsen outcome when an intentional overdose has occurred. Examples of such agents include ethanol,
         <a class="drug drug_pediatric" data-topicid="13393" href="/z/d/drug information/13393.html" rel="external">
          isoniazid
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="12767" href="/z/d/drug information/12767.html" rel="external">
          rifampin
         </a>
         [
         <a href="#rid70">
          70,71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, drugs that compete for glucuronidation pathways (eg,
         <a class="drug drug_pediatric" data-topicid="12816" href="/z/d/drug information/12816.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="13007" href="/z/d/drug information/13007.html" rel="external">
          zidovudine
         </a>
         ) may potentiate
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         hepatotoxicity by increasing the CYP2E1-dependent metabolism of acetaminophen [
         <a href="#rid72">
          72
         </a>
         ]. However, there are no systematic studies that demonstrate a consistent increased associated risk with these medications.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic background
         </strong>
         – Polymorphisms in the cytochrome oxidase enzyme system may contribute to diminished or excessive oxidative metabolism of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         , and thereby affect predisposition to hepatic injury [
         <a href="#rid73">
          73,74
         </a>
         ]. However, there are no systematic studies that demonstrate a consistent increased associated risk with known genetic variants.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5084979">
         <span class="h1">
          DOSAGE FORMS
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          Acetaminophen
         </a>
         is available in the following preparations  (
         <a class="graphic graphic_table graphicRef79854" href="/z/d/graphic/79854.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immediate-release for oral administration (eg, liquids, caplets, capsules, tablets)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immediate release suppositories
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sustained-release oral tablets (eg, bilayer tablets of Tylenol Extended Relief) formulations
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intravenous formulation (10 mg/mL concentration)
        </p>
        <p>
        </p>
        <p>
         Among the oral formulations, the concentration may range from 32 to 33 mg/mL (syrups, elixirs) for liquid preparations in the United States, and the strength may range from 80 to 650 mg for pills, capsules, or suppositories. Although the 100 mg/mL infant formulation was discontinued in the United States in 2011, it is still available in some countries. Given the variety of formulations and range of doses within similar formulations (eg, chewable tablets), the potential for unintentional overdose due to confusion over concentration and frequency is high [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5084986">
         <span class="h1">
          TOXIC DOSE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The therapeutic dose of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         for children younger than 12 years is 10 to 15 mg/kg per dose, every four to six hours, not to exceed five doses per 24-hour period (maximum daily dose 75 mg/kg). The therapeutic dose for children 12 years and older and adults is 325 to 1000 mg per dose every four to six hours (maximum daily dose 4 g). Therapeutic serum concentrations range from 10 to 20 mcg/mL (66 to 132 micromol/L).
        </p>
        <p>
         The toxic dose may vary among individuals according to baseline glutathione levels and other factors (see
         <a class="local">
          'Risk factors in children'
         </a>
         above) but in general:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The minimal toxic dose for an acute ingestion is 150 mg/kg for a child or 7.5 to 10 g for an adult [
         <a href="#rid76">
          76
         </a>
         ]. Referral for emergency department evaluation is generally recommended for acute ingestions greater than 200 mg/kg in children younger than six years of age or 10 g, whichever is
         <strong>
          less
         </strong>
         . (See
         <a class="local">
          'Acute overdoses'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Toxicity is likely to occur with acute ingestions greater than 250 mg/kg or ingestions of greater than 12 g in a 24-hour period [
         <a href="#rid77">
          77,78
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Virtually all patients who ingest doses in excess of 350 mg/kg develop severe liver toxicity (defined as peak aspartate aminotransferase [AST] or alanine aminotransferase [ALT] concentrations greater than 1000 international units/L) unless treated [
         <a href="#rid77">
          77
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In repeated supratherapeutic overdose (eg, multiple oral or rectal doses amounting to a supratherapeutic dose of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         ), the minimum toxic threshold for children appears to be 150 to 175 mg/kg per day over two to four days, particularly in the setting of a febrile illness and decreased oral intake [
         <a href="#rid3">
          3-5
         </a>
         ]. (See
         <a class="local">
          'Repeated supratherapeutic ingestion'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5084993">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The initial manifestations of acute
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         poisoning in children and adolescents are often mild and nonspecific, and do not predict subsequent hepatotoxicity [
         <a href="#rid79">
          79
         </a>
         ]. Nonetheless, clinicians must promptly recognize acetaminophen poisoning in order to minimize subsequent morbidity and mortality because
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         , the antidote for acetaminophen, is most effective if administered within 8 to 10 hours of ingestion [
         <a href="#rid80">
          80-82
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5085000">
         <span class="h2">
          Acute exposures
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical course of acute exposures (defined as any pattern of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         ingestion as long as the serum concentration can be measured within 24 hours of swallowing the first dose [
         <a href="#rid2">
          2
         </a>
         ]) is often divided into four sequential stages. These stages  (
         <a class="graphic graphic_table graphicRef57032" href="/z/d/graphic/57032.html" rel="external">
          table 2
         </a>
         ) are described in detail separately and include the following (see
         <a class="medical medical_review" href="/z/d/html/340.html" rel="external">
          "Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and evaluation"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stage I (up to 24 hours after overdose)
         </strong>
         – Asymptomatic but less commonly: nausea, vomiting, and, in patients with very large doses, lethargy and malaise
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stage II (24 to 72 hours after overdose)
         </strong>
         – Right upper quadrant pain, elevation in liver aminotransferases, and prothrombin time (PT)/international normalized ratio of PT (INR), and, in severe cases, evidence of nephrotoxicity (elevated blood urea nitrogen, creatinine, oliguria) and/or pancreatitis (elevated serum amylase, lipase)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stage III (72 to 96 hours)
         </strong>
         – Evidence of hepatic failure and, in severe cases, kidney failure and multi-organ failure; death most commonly occurs in this stage
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stage IV (4 to 14 days)
         </strong>
         – Recovery
        </p>
        <p>
        </p>
        <p>
         Patients with high-risk ingestions (typically &gt;350 mg/kg or &gt;30 grams) can develop altered mental status and a metabolic acidosis with hyperlactemia early (ie, within eight hours) following ingestion [
         <a href="#rid83">
          83
         </a>
         ]. Toxicity is from the
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         itself (ie, parent compound) instead of the metabolites, likely from mitochondrial dysfunction and not liver injury. Management follows similar principles, but activated charcoal may be given in a delayed fashion, an increased
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         dose may be warranted, and hemodialysis may be recommended in some cases [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children", section on 'High-risk patients'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5085007">
         <span class="h2">
          Repeated supratherapeutic ingestion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnosis of repeated supratherapeutic toxicity is often difficult and requires the combination of astute history-taking and recognition of typical clinical and laboratory abnormalities. Clinicians must specifically ask about
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         ingestion (including dose and frequency of administration) because patients and caregivers may not include it when asked about potentially toxic drugs. Signs and symptoms are insidious in onset, often nonspecific, and easily confused with alternative diagnoses (eg, viral syndrome). Serum concentrations of acetaminophen in this setting do not correlate with toxicity [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Establishing the diagnosis of repeated supratherapeutic
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         poisoning frequently involves exclusion of other causes of clinical hepatitis. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H5085014">
         <span class="h1">
          EVALUATION AND DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The need for emergency department evaluation of children and adolescents with
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         intoxication varies depending upon the age of the child and the maximum possible ingested dose. Most pediatric acetaminophen exposures are low-dose exposures that do not require medical attention [
         <a href="#rid18">
          18
         </a>
         ]. Consultation with a regional poison control center is encouraged when making triage decisions. (See
         <a class="local">
          'Regional poison control centers'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H5085021">
         <span class="h2">
          Acute overdoses
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because most children and adolescents with acute
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         overdose are asymptomatic at presentation, the history of exposure largely determines the need for medical evaluation, laboratory testing, and treatment. An acute overdose is defined as any pattern of acetaminophen ingestion as long as the serum concentration can be measured within 24 hours of swallowing the first dose [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prehospital triage
         </strong>
         – Prehospital evaluation involves determination of the maximal possible dose, pattern of ingestion, and whether the child has any risks for hepatotoxicity (eg, fasting, coingestion of other drugs, underlying medical conditions). Consultation with a poison control center (see
         <a class="local">
          'Regional poison control centers'
         </a>
         below) is helpful in assessing the need for emergency referral, particularly if the ingested product contains other pharmaceuticals, such as opiates (eg,
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         with
         <a class="drug drug_pediatric" data-topicid="13178" href="/z/d/drug information/13178.html" rel="external">
          codeine
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12666" href="/z/d/drug information/12666.html" rel="external">
          oxycodone
         </a>
         , antihistamine, etc) or is an extended-release product. Some health care providers may choose to refer children younger than six years of age with acute acetaminophen exposures that are less than 200 mg/kg, especially when significant uncertainty exists concerning the maximum ingested acetaminophen dose and/or the patient's weight.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Consensus guidelines developed by America’s Poison Centers and based upon observational studies suggest that children and adolescents who meet the following criteria after acute overdose be referred to an emergency department for evaluation of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         toxicity [
         <a href="#rid84">
          84
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Exposure to 200 mg/kg or 10 g, whichever is
         <strong>
          less
         </strong>
         , acutely or over 24 hours
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ingestion of an unknown amount of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ingestion of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         with intent for self-harm
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Known exposure to
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         with signs of toxicity (eg, vomiting, right upper quadrant pain, altered mental status)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          History
         </strong>
         – The evaluation of the child or adolescent with
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         intoxication should include as much detail about the ingestion as possible.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When did the ingestion occur?
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         How much
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         was ingested? (The strength or concentration of acetaminophen in the product of concern must be carefully delineated)  (
         <a class="graphic graphic_table graphicRef79854" href="/z/d/graphic/79854.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Was the child or adolescent taking
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         on a regular basis (including in over-the-counter preparations)?
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Was the ingestion intentional with a desire for self-harm?
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Does the child or adolescent have any underlying medical problems or take any medication on a regular basis?
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Does the child or adolescent have symptoms (nausea, vomiting, diaphoresis, pallor, lethargy, malaise, right upper quadrant pain, hepatomegaly)?
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physical examination
         </strong>
         – Most children with acute
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         overdoses present for care soon after ingestion and are asymptomatic with a normal physical examination. Examination of children with acetaminophen intoxication should include evaluation for encephalopathy, jaundice, right upper quadrant pain, liver enlargement and/or tenderness, and bleeding. Because the clinical manifestations of acetaminophen intoxication occur in distinct stages  (
         <a class="graphic graphic_table graphicRef57032" href="/z/d/graphic/57032.html" rel="external">
          table 2
         </a>
         ), the examination must be repeated over time.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The clinical features of toxic metabolic encephalopathy are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6154.html" rel="external">
          "Acute toxic-metabolic encephalopathy in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5085028">
         <span class="h2">
          Repeated supratherapeutic ingestion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Consensus guidelines developed by America’s Poison Centers and based upon observational studies suggest that children and adolescents who meet the following criteria be referred to an emergency department for evaluation of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         toxicity after the following supratherapeutic exposures [
         <a href="#rid84">
          84
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         150 mg/kg or 6 g, whichever is
         <strong>
          less
         </strong>
         , per 24-hour period over 48 hours
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In children less than six years of age, 100 mg/kg or more per 24-hour period for the preceding 72 hours or longer
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children with conditions that predispose to
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         toxicity (eg, fasting, liver disease) with an ingestion of 100 mg/kg or 4 g, per 24-hour period, whichever is
         <strong>
          less
         </strong>
        </p>
        <p>
        </p>
        <p>
         We obtain an
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentration, aspartate aminotransferase (AST), alanine aminotransferase (ALT), prothrombin time (PT)/international normalized ratio of PT (INR), and bilirubin in children who have received multiple excessive doses of acetaminophen if they have any of the following [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If ingestion period was ≤ 24 hours – Ingestion of greater than 200 mg/kg/day (or &gt;10 g/day if this is lower) of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If ingestion period was 24 to 48 hours – Ingestion of greater 150 mg/kg/day (or &gt;6 g/day if this is lower) of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If ingestion period &gt; 48 hours – Ingestion of greater 100 mg/kg/day (or &gt;4 g/day if this is lower) of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abdominal pain or right upper quadrant tenderness, nausea, vomiting, jaundice, ill appearing, or mental status changes.
        </p>
        <p>
        </p>
        <p>
         The Revised Rumack-Matthew nomogram for
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         poisoning should
         <strong>
          not
         </strong>
         be used to determine the risk of toxicity. The Revised Rumack-Matthew nomogram was derived from patients who had ingested doses within 24 hours of measurement of the serum acetaminophen concentration so it
         <strong>
          cannot
         </strong>
         be used for risk stratification of patients who have multiple ingestions over more than 24 hours [
         <a href="#rid2">
          2
         </a>
         ]. The last dose
         <strong>
          cannot
         </strong>
         be used as a surrogate for single-point ingestions because earlier exposure may have caused hepatic injury [
         <a href="#rid3">
          3
         </a>
         ]. If the aminotransferases are elevated, the patient should have renal function and international normalized ratio measured.
        </p>
        <p>
         Elevation of AST or ALT indicates hepatic injury, regardless of the serum
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentration and treatment with
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         should be provided. As an example, of 249 patients over the age of 12 years who had received more than 4 g per 24 hours of acetaminophen, 15 percent with AST of 50 to 1000 international units/L developed liver toxicity and 16 percent with serum AST &gt;1000 international units/L died or received liver transplants [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
         Children who have residual
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         (&gt;20 mcg/mL [66 micromol/L]) but normal AST and ALT and a history suggestive of acetaminophen overdose may also be at risk for hepatic injury and warrant antidotal therapy with
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         .
        </p>
        <p>
         Consultation with a regional poison control center (see
         <a class="local">
          'Regional poison control centers'
         </a>
         below) or a medical toxicologist can help in tailoring duration of therapy and monitoring disease progression. The management of these children is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children", section on 'Patient with reliable history and repeated supratherapeutic ingestion'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5085035">
         <span class="h2">
          Laboratory evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients with a history of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         overdose should undergo measurement of serum acetaminophen concentration. In patients who are expected to develop hepatic toxicity based upon history and initial serum acetaminophen concentration, additional laboratory tests include ALT, AST, electrolytes, blood urea nitrogen (BUN), creatinine. These studies should also be performed in patients who ingested repeated supratherapeutic doses. In addition, ill-appearing patients or those with altered mental status need blood gas analysis to determine serum pH, serum lactate, prothrombin time (PT)/international normalized ratio of PT (INR), and bilirubin to quantify hepatic dysfunction. (See
         <a class="medical medical_review" href="/z/d/html/6496.html" rel="external">
          "Approach to the child with occult toxic exposure"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5085042">
         <span class="h3">
          Acetaminophen concentration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following an acute ingestion, the risk of toxicity is best predicted by relating the time of ingestion to the serum
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentration. The dose history helps guide treatment decisions, but it is not sufficient evidence on which to base treatment after an acute overdose. Most studies have found only weak correlation between the amount of acetaminophen reportedly ingested and the serum concentration measured [
         <a href="#rid10">
          10,86,87
         </a>
         ].
        </p>
        <p>
         For an acute overdose, the serum
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentration should be measured as soon as possible as long as at least four hours have passed since the start of the ingestion. There is limited utility to serum concentrations measured less than four hours after ingestion [
         <a href="#rid88">
          88
         </a>
         ]. The concentration should be plotted on the Revised Rumack-Matthew nomogram to determine the need for
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         therapy  (
         <a class="graphic graphic_figure graphicRef83590" href="/z/d/graphic/83590.html" rel="external">
          figure 2
         </a>
         ). While there is universal agreement that acetylcysteine is effective for the prevention of hepatic injury when administered soon after acetaminophen overdose, the exact guidelines for the initiation of treatment vary throughout the world. The Rumack-Matthew nomogram (four hour concentration of 150 mg/L) has been used in the United States for more than 30 years and is the author's preferred tool to guide treatment because of its safety and efficacy [
         <a href="#rid89">
          89,90
         </a>
         ]. Other guidelines have also been published [
         <a href="#rid91">
          91,92
         </a>
         ].
        </p>
        <p>
         A concentration at or above the line that starts at 300 mg/L at four hours on the Revised Rumack-Matthew Treatment nomogram  (
         <a class="graphic graphic_figure graphicRef83590" href="/z/d/graphic/83590.html" rel="external">
          figure 2
         </a>
         ) suggests a high-risk ingestion [
         <a href="#rid2">
          2
         </a>
         ]. Consultation with a regional poison control center (see
         <a class="local">
          'Regional poison control centers'
         </a>
         below) or a medical toxicologist is strongly encouraged as these patients may need an increased dose of
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         and may benefit from delayed activated charcoal administration. (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children", section on 'High-risk patients'
         </a>
         .)
        </p>
        <p>
         Although the peak concentration after an intravenous overdose will occur sooner than after oral ingestion, a four-hour concentration is still recommended [
         <a href="#rid30">
          30
         </a>
         ]. Until more experience with intravenous
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         overdose is obtained, the clinician is encouraged to contact a regional poison control center for assistance with assessment and management of these patients. (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children", section on 'Patient with Iatrogenic intravenous overdose'
         </a>
         and
         <a class="local">
          'Additional resources'
         </a>
         below.)
        </p>
        <p>
         Following an ingestion that involves an extended-release formulation (labeled for use on an eight-hour basis) or a co-ingestion with an anticholinergic agent or opioid, the Revised Rumack-Matthew nomogram can be used to assess risk if the concentration is at or above the treatment line (ie, therapy with
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         is indicated) [
         <a href="#rid2">
          2
         </a>
         ]. A repeat concentration is not needed if the concentration was ≤10 mcg/mL (66 micromol/L). Following an extend-release ingestion, if the concentration obtained between 4 to 12 hours after ingestion is below the treatment line but &gt;10 mcg/mL (66 micromol/L), we measure another concentration four to six hours after the first measurement. Following a co-ingestion with an anticholinergic agent or opioid, if the
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentration measured 4 to 24 hours after ingestion is below the treatment line but &gt;10 mcg/mL, we measure another concentration four to six hours after the first measurement. The second concentration is plotted versus the number of hours since the ingestion and if either concentration is above the treatment line, acetylcysteine is indicated.
        </p>
        <p>
         Observational evidence from Australia suggests that ingestion of modified release products may increase the risk of delayed or multiple peak serum concentrations and that these patients are at increased risk for prolonged absorption and need for prolonged treatment [
         <a href="#rid93">
          93
         </a>
         ]. This product is different than the modified release product available in the United States and Canada. However, given the risk of prolonged absorption, early treatment and poison center consultation is warranted for these cases.
        </p>
        <p>
         Most clinical chemistry laboratories report the plasma
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentrations in mcg/mL rather than micromol/L. The units should be confirmed to ensure proper plotting on the Revised Rumack-Matthew nomogram for acetaminophen poisoning. To convert mcg/mL to micromol/L, multiply by 6.62.
        </p>
        <p>
         Serum
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentrations obtained before four hours may be useful in detecting occult acetaminophen ingestions in patients who do not (or cannot) provide an ingestion history. However, because concentrations obtained before four hours may not represent peak concentrations, they should be repeated at four hours [
         <a href="#rid79">
          79
         </a>
         ], and the four-hour concentration plotted on the Revised Rumack-Matthew nomogram. A nondetectable concentration measured between two to four hours after ingestion typically excludes risk for significant toxicity; consultation with a poison center or medical toxicologist is recommended if the decision is made to not obtain a concentration at four hours in this situation [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="local">
          'Regional poison control centers'
         </a>
         below.)
        </p>
        <p>
         Serum
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentrations obtained more than 24 hours after ingestion are difficult to interpret. Patients with an unknown time of ingestion and a serum acetaminophen concentration &gt;10 mcg/mL (66 micromol/L) and/or elevation of aminotransferases are usually treated with
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/318.html" rel="external">
          "Acetaminophen (paracetamol) poisoning: Management in adults and children", section on 'Patient with unreliable history'
         </a>
         .)
        </p>
        <p>
         Measuring a screening serum
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         concentration is recommended for all patients with a history of overdose or altered mental status thought to be caused by overdose (see
         <a class="medical medical_review" href="/z/d/html/324.html" rel="external">
          "General approach to drug poisoning in adults"
         </a>
         ). However, in some cases, there is no practical way to ascertain the time of ingestion, making it impossible to use the Revised Rumack-Matthew nomogram for risk stratification. In these situations, our approach, for patients in whom an acute ingestion has occurred is to narrow the ingestion time to a specific window (eg, the patient had been continually observed until 12 hours prior to admission so the ingestion could not have occurred more than 12 hours ago), it may be possible to construct a worst possible scenario and plot the measured serum concentration using the "last known time prior to ingestion" as the time of ingestion.
        </p>
        <p class="headingAnchor" id="H151833225">
         <span class="h3">
          Acetaminophen-protein adducts
         </span>
         <span class="headingEndMark">
          —
         </span>
         The oxidation of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         by hepatic enzymes forms a reactive metabolite that may bind to hepatic proteins. This hepatic acetaminophen-protein adduct is released into serum and can be quantified. Quantification of these adducts may be helpful in determining if acetaminophen is responsible for acute liver injury [
         <a href="#rid94">
          94-96
         </a>
         ]. However, the test is not widely available and has most commonly been used to retrospectively determine the cause of acute liver failure.
        </p>
        <p class="headingAnchor" id="H5085049">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The history of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         ingestion may or may not be known. Unlike many other etiologies of hepatitis, acetaminophen-induced hepatitis is acute in onset and progresses rapidly; in severe exposure with delayed presentation or untreated with
         <a class="drug drug_pediatric" data-topicid="13239" href="/z/d/drug information/13239.html" rel="external">
          acetylcysteine
         </a>
         , it is characterized by marked elevation of plasma aminotransferases (greater than 3000 international units/L) and is associated with a rising prothrombin time (PT). In cases of occult exposure, the differential diagnosis includes other causes of hepatic failure:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Viral hepatitis (hepatitis A, hepatitis B, hepatitis C, Epstein-Barr virus, cytomegalovirus, varicella)
         </strong>
         – Viral hepatitis usually can be distinguished from acetaminophen-induced liver injury by aminotransferases that are almost always less than 3000 international units/L and positive serology. (See
         <a class="medical medical_review" href="/z/d/html/5942.html" rel="external">
          "Overview of hepatitis A virus infection in children", section on 'Diagnosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5943.html" rel="external">
          "Clinical manifestations and diagnosis of hepatitis B virus infection in children and adolescents", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ischemic hepatitis ("shock liver")
         </strong>
         – Ischemic hepatitis typically follows a period of severe, prolonged hypotension. Other features suggestive of ischemic hepatitis include an early rise in serum lactate dehydrogenase (LDH), a ratio of serum alanine aminotransferase (ALT) to LDH &lt;1.5 early in the course, and a rapid fall in serum aminotransferase concentrations after the initial rise. (See
         <a class="medical medical_review" href="/z/d/html/3593.html" rel="external">
          "Ischemic hepatitis, hepatic infarction, and ischemic cholangiopathy", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inborn errors of metabolism (eg, Wilson disease, alpha-1 antitrypsin deficiency, fatty acid oxidation abnormalities)
         </strong>
         – These diseases tend to progress slowly and are typically associated with elevations in plasma aminotransferases that are less than 1000 international units/L. Characteristic associated findings and specific testing can confirm the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/6197.html" rel="external">
          "Metabolic myopathies caused by disorders of lipid and purine metabolism"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83837.html" rel="external">
          "Wilson disease: Clinical manifestations, diagnosis, and natural history", section on 'Diagnostic evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1464.html" rel="external">
          "Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency", section on 'Evaluation and diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Drug- or toxin-induced hepatitis
         </strong>
         – A variety of toxic agents can cause acute hepatitis, which in many circumstances may be clinically indistinguishable from
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         poisoning  (
         <a class="graphic graphic_table graphicRef79913" href="/z/d/graphic/79913.html" rel="external">
          table 3
         </a>
         ). Known exposure to these agents, absence of any history of acetaminophen exposure, and no clinically detectable serum acetaminophen help establish the diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hepatobiliary disease
         </strong>
         – Most children with hepatobiliary disease have a history of biliary atresia, long-term requirement for hyperalimentation, or predisposition to pigmentary gallstones (eg, sickle cell anemia, hemolytic anemia).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reye syndrome
         </strong>
         – Reye syndrome is a rare cause of rapidly progressive encephalopathy with hepatic failure that often begins several days after apparent recovery from a viral illness, especially varicella or influenza A or B. This disease has virtually disappeared in concert with advisories
         <strong>
          not
         </strong>
         to use salicylates in febrile children. The liver pathology typically shows steatosis rather than the centrilobular necrosis that is characteristic of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         poisoning. (See
         <a class="medical medical_review" href="/z/d/html/6154.html" rel="external">
          "Acute toxic-metabolic encephalopathy in children", section on 'Reye syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5087304">
         <span class="h1">
          ADDITIONAL RESOURCES
         </span>
        </p>
        <p class="headingAnchor" id="H2198033754">
         <span class="h2">
          Regional poison control centers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/138307.html" rel="external">
          "Society guideline links: Regional poison control centers"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3307346972">
         <span class="h2">
          Society guideline links
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/114014.html" rel="external">
          "Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5087276">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patterns of exposure
         </strong>
         – The majority of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         overdoses in children younger than six years of age involve acute ingestions that are typically exploratory and have a low likelihood for serious toxicity. Multiple supratherapeutic doses of acetaminophen in young children administered orally or rectally by caregivers or large iatrogenic intravenous dosing errors also can be associated with toxicity. (See
         <a class="local">
          'Unintentional'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Acute intentional ingestions in children older than six years of age and adolescents (ie, suicide attempts) have a higher potential for serious
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         toxicity and may also involve multiple ingestants in addition to acetaminophen when compared with exploratory ingestions in younger children. (See
         <a class="local">
          'Intentional'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Toxic dose
         </strong>
         – The toxic dose of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         depends upon the age of the child and whether the exposure is acute or repeated supratherapeutic dosing. The minimal toxic dose for an acute ingestion is 150 mg/kg, and toxicity is likely to occur with ingestions &gt;250 mg/kg in a 24-hour period. (See
         <a class="local">
          'Toxic dose'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications for emergency department referral
         </strong>
         – Referral for emergency department evaluation is generally recommended for acute ingestions greater than 200 mg/kg in children younger than six years of age or 10 g, whichever is
         <strong>
          less
         </strong>
         ; intentional ingestions with a desire for self-harm; patients who are symptomatic; or situations where the ingested dose is unknown. Consultation with a poison control center is helpful in assessing the need for emergency referral, particularly if the ingested product contains other pharmaceuticals, such as opiates (eg,
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         with
         <a class="drug drug_pediatric" data-topicid="13178" href="/z/d/drug information/13178.html" rel="external">
          codeine
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12666" href="/z/d/drug information/12666.html" rel="external">
          oxycodone
         </a>
         , antihistamine, etc) or is an extended-release product. (See
         <a class="local">
          'Acute overdoses'
         </a>
         above and
         <a class="local">
          'Regional poison control centers'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – The stages of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         toxicity are described in the table  (
         <a class="graphic graphic_table graphicRef57032" href="/z/d/graphic/57032.html" rel="external">
          table 2
         </a>
         ). Patients who present within 24 hours after an acute acetaminophen overdose are generally asymptomatic with a normal physical examination. Patients with high-risk ingestions (typically &gt;350 mg/kg or &gt;30 grams) can develop altered mental status and a metabolic acidosis with hyperlactemia early (ie, within eight hours) following ingestion. Patients who present more than 24 hours after a potentially toxic acetaminophen overdose are more likely to have manifestations of hepatotoxicity. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute overdose
         </strong>
         – This is defined as any pattern of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         ingestion as long as the serum concentration can be measured within 24 hours of swallowing the first dose. The likelihood for serious toxicity is determined by plotting a serum acetaminophen concentration obtained between 4 and 24 hours after the initial ingestion on the Revised Rumack-Matthew nomogram  (
         <a class="graphic graphic_figure graphicRef83590" href="/z/d/graphic/83590.html" rel="external">
          figure 2
         </a>
         ). (See
         <a class="local">
          'Acute overdoses'
         </a>
         above and
         <a class="local">
          'Laboratory evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Repeated supratherapeutic ingestion
         </strong>
         – Toxicity following repeated administration amounting to a supratherapeutic dose of
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          acetaminophen
         </a>
         may be difficult to diagnose unless the caregivers are specifically questioned about acetaminophen and over-the-counter medication use (eg, dose, preparation, dosing interval). Patients should be evaluated with a serum acetaminophen concentration, aspartate aminotransferase (AST), alanine aminotransferase (ALT), prothrombin time (PT)/international normalized ratio of PT (INR), and bilirubin. The Revised Rumack-Matthew nomogram should
         <strong>
          not
         </strong>
         be used to determine the risk of toxicity. Children with elevated ALT/AST or residual acetaminophen after prolonged acetaminophen overdoses are at risk for hepatotoxicity. Consultation with a poison control center or medical toxicologist is encouraged to guide assessment of poisoning risk and need for specific treatment. (See
         <a class="local">
          'Repeated supratherapeutic ingestion'
         </a>
         above and
         <a class="local">
          'Laboratory evaluation'
         </a>
         above and
         <a class="local">
          'Regional poison control centers'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – In cases of occult exposure, the differential diagnosis includes other causes of severe liver injury. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J 1966; 2:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dart RC, Mullins ME, Matoushek T, et al. Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement. JAMA Netw Open 2023; 6:e2327739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sztajnkrycer MJ, Bond GR. Chronic acetaminophen overdosing in children: risk assessment and management. Curr Opin Pediatr 2001; 13:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rivera-Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998; 132:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila) 2020; 58:1360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Myers WC, Otto TA, Harris E, et al. Acetaminophen overdose as a suicidal gesture: a survey of adolescents' knowledge of its potential for toxicity. J Am Acad Child Adolesc Psychiatry 1992; 31:686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hickson GB, Altemeier WA, Martin ED, Campbell PW. Parental administration of chemical agents: a cause of apparent life-threatening events. Pediatrics 1989; 83:772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hickson GB, Greene JW, Ghishan FK, Craft LT. Apparent intentional poisoning of an infant with acetaminophen. Am J Dis Child 1983; 137:917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gee P, Ardagh M. Paediatric exploratory ingestions of paracetamol. N Z Med J 1998; 111:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kearns GL, Leeder JS, Wasserman GS. Acetaminophen intoxication during treatment: what you don't know can hurt you. Clin Pediatr (Phila) 2000; 39:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blake KV, Bailey D, Zientek GM, Hendeles L. Death of a child associated with multiple overdoses of acetaminophen. Clin Pharm 1988; 7:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith DW, Isakson G, Frankel LR, Kerner JA Jr. Hepatic failure following ingestion of multiple doses of acetaminophen in a young child. J Pediatr Gastroenterol Nutr 1986; 5:822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nadir A, McFadden R, Griggs J, et al. Parental and medical over-administration of acetaminophen causing lethal hepatotoxicity in a 10-year-old. J Okla State Med Assoc 1994; 87:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hynson JL, South M. Childhood hepatotoxicity with paracetamol doses less than 150 mg/kg per day. Med J Aust 1999; 171:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Penna AC, Dawson KP, Penna CM. Is prescribing paracetamol 'pro re nata' acceptable? J Paediatr Child Health 1993; 29:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohler CR, Nordt SP, Williams SR, et al. Prospective evaluation of mild to moderate pediatric acetaminophen exposures. Ann Emerg Med 2000; 35:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bond GR, Krenzelok EP, Normann SA, et al. Acetaminophen ingestion in childhood--cost and relative risk of alternative referral strategies. J Toxicol Clin Toxicol 1994; 32:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heubi JE, Bien JP. Acetaminophen use in children: more is not better. J Pediatr 1997; 130:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miles FK, Kamath R, Dorney SF, et al. Accidental paracetamol overdosing and fulminant hepatic failure in children. Med J Aust 1999; 171:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brass EP, Reynolds KM, Burnham RI, Green JL. Medication Errors With Pediatric Liquid Acetaminophen After Standardization of Concentration and Packaging Improvements. Acad Pediatr 2018; 18:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kearns GL, Leeder JS, Wasserman GS. Acetaminophen overdose with therapeutic intent. J Pediatr 1998; 132:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mofenson HC, McFee R, Caraccio T, Greensher J. Combined antipyretic therapy: another potential source of chronic acetaminophen toxicity. J Pediatr 1998; 133:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heard K, Bui A, Mlynarchek SL, et al. Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases. Am J Ther 2014; 21:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alander SW, Dowd MD, Bratton SL, Kearns GL. Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury. Arch Pediatr Adolesc Med 2000; 154:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kozer E, Barr J, Bulkowstein M, et al. A prospective study of multiple supratherapeutic acetaminophen doses in febrile children. Vet Hum Toxicol 2002; 44:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henretig FM, Selbst SM, Forrest C, et al. Repeated acetaminophen overdosing. Causing hepatotoxicity in children. Clinical reports and literature review. Clin Pediatr (Phila) 1989; 28:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James LP, Wilson JT, Simar R, et al. Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network. Clin Pediatr (Phila) 2001; 40:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gray T, Hoffman RS, Bateman DN. Intravenous paracetamol--an international perspective of toxicity. Clin Toxicol (Phila) 2011; 49:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dart RC, Rumack BH. Intravenous acetaminophen in the United States: iatrogenic dosing errors. Pediatrics 2012; 129:349.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982; 7:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bizovi KE, Aks SE, Paloucek F, et al. Late increase in acetaminophen concentration after overdose of Tylenol Extended Relief. Ann Emerg Med 1996; 28:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cetaruk EW, Dart RC, Hurlbut KM, et al. Tylenol Extended Relief overdose. Ann Emerg Med 1997; 30:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stork CM, Rees S, Howland MA, et al. Pharmacokinetics of extended relief vs regular release Tylenol in simulated human overdose. J Toxicol Clin Toxicol 1996; 34:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tighe TV, Walter FG. Delayed toxic acetaminophen level after initial four hour nontoxic level. J Toxicol Clin Toxicol 1994; 32:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birmingham PK, Tobin MJ, Henthorn TK, et al. Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations. Anesthesiology 1997; 87:244.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Lingen RA, Deinum HT, Quak CM, et al. Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants. Clin Pharmacol Ther 1999; 66:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cullen S, Kenny D, Ward OC, Sabra K. Paracetamol suppositories: a comparative study. Arch Dis Child 1989; 64:1504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Douglas DR, Sholar JB, Smilkstein MJ. A pharmacokinetic comparison of acetaminophen products (Tylenol Extended Relief vs regular Tylenol). Acad Emerg Med 1996; 3:740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schiødt FV, Ott P, Christensen E, Bondesen S. The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther 2002; 71:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bessems JG, Vermeulen NP. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 2001; 31:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell JR, Thorgeirsson SS, Potter WZ, et al. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther 1974; 16:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miners JO, Drew R, Birkett DJ. Mechanism of action of paracetamol protective agents in mice in vivo. Biochem Pharmacol 1984; 33:2995.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973; 187:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973; 187:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003; 349:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rumore MM, Blaiklock RG. Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity. J Pharm Sci 1992; 81:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarloff JB, Khairallah EA, Cohen SD, Goldstein RS. Sex- and age-dependent acetaminophen hepato- and nephrotoxicity in Sprague-Dawley rats: role of tissue accumulation, nonprotein sulfhydryl depletion, and covalent binding. Fundam Appl Toxicol 1996; 30:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rumack BH. Acetaminophen overdose in young children. Treatment and effects of alcohol and other additional ingestants in 417 cases. Am J Dis Child 1984; 138:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rumack BH, Peterson RG. Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics 1978; 62:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Penna A, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol 1991; 32:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peterson RG, Rumack BH. Age as a variable in acetaminophen overdose. Arch Intern Med 1981; 141:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther 1976; 19:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lauterburg BH, Vaishnav Y, Stillwell WG, Mitchell JR. The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther 1980; 213:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schiødt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997; 337:1112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272:1845.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Price VF, Jollow DJ. Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat. Biochem Pharmacol 1989; 38:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Price VF, Miller MG, Jollow DJ. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol 1987; 36:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLean AE. Nutrition and the intracellular site of toxic injury. World Rev Nutr Diet 1978; 29:124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sauerwein RW, Mulder JA, Mulder L, et al. Inflammatory mediators in children with protein-energy malnutrition. Am J Clin Nutr 1997; 65:1534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pessayre D, Dolder A, Artigou JY, et al. Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 1979; 77:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kozer E, Evans S, Barr J, et al. Glutathione, glutathione-dependent enzymes and antioxidant status in erythrocytes from children treated with high-dose paracetamol. Br J Clin Pharmacol 2003; 55:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahata MC, Powell DA, Durrell DE, Miller MA. Acetaminophen accumulation in pediatric patients after repeated therapeutic doses. Eur J Clin Pharmacol 1984; 27:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alonso EM, Sokol RJ, Hart J, et al. Fulminant hepatitis associated with centrilobular hepatic necrosis in young children. J Pediatr 1995; 127:888.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Morais SM, Uetrecht JP, Wells PG. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology 1992; 102:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esteban A, Pérez-Mateo M. Gilbert's disease: a risk factor for paracetamol overdosage? J Hepatol 1993; 18:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ullrich D, Sieg A, Blume R, et al. Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur J Clin Invest 1987; 17:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benson GD. Acetaminophen in chronic liver disease. Clin Pharmacol Ther 1983; 33:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farrell GC, Cooksley WG, Powell LW. Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes. Clin Pharmacol Ther 1979; 26:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bray GP, Harrison PM, O'Grady JG, et al. Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol 1992; 11:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nolan CM, Sandblom RE, Thummel KE, et al. Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. Chest 1994; 105:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shriner K, Goetz MB. Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. Am J Med 1992; 93:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ueshima Y, Tsutsumi M, Takase S, et al. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcohol Clin Exp Res 1996; 20:25A.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Critchley JA, Nimmo GR, Gregson CA, et al. Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 1986; 22:649.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis RK, Paloucek FP. Assessment and treatment of acetaminophen overdose. Clin Pharm 1991; 10:765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prescott LF. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs 1983; 25:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995; 109:1907.
          </a>
         </li>
         <li class="breakAll">
          Smilkstein MJ. Acetaminophen. In: Goldfrank's Toxicologic Emergencies, Goldfrank LR, Flomenbaum NE, Lewin NA, et al (Eds), Appleton &amp; Lange, Stanford 1998. p.541.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smilkstein MJ, Bronstein AC, Linden C, et al. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991; 20:1058.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J 1979; 2:1097.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988; 319:1557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiew AL, Isbister GK, Kirby KA, et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol (Phila) 2017; 55:1055.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dart RC, Erdman AR, Olson KR, et al. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2006; 44:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daly FF, O'Malley GF, Heard K, et al. Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med 2004; 44:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Read RB, Tredger JM, Williams R. Analysis of factors responsible for continuing mortality after paracetamol overdose. Hum Toxicol 1986; 5:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ambre J, Alexander M. Liver toxicity after acetaminophen ingestion. Inadequacy of the dose estimate as an index of risk. JAMA 1977; 238:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yarema MC, Green JP, Sivilotti ML, et al. Can a serum acetaminophen concentration obtained less than 4 hours post-ingestion determine which patients do not require treatment with acetylcysteine?(). Clin Toxicol (Phila) 2017; 55:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975; 55:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gosselin S, Hoffman RS, Juurlink DN, et al. Treating acetaminophen overdose: thresholds, costs and uncertainties. Clin Toxicol (Phila) 2013; 51:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clemmesen JO, Ott P, Dalhoff KP, et al. [Recommendations for treatment of paracetamol poisoning. Danish Medical Society, Study of the Liver]. Ugeskr Laeger 1996; 158:6892.
          </a>
         </li>
         <li class="breakAll">
          Paracetamol overdose: new guidance on treatment with intravenous acetylcysteine. Drug Safety Update. Medicines and Healthcare products Regulatory Agency. United Kingdom. Available at http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON185624 (Accessed March 6, 2014).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiew AL, Isbister GK, Page CB, et al. Modified release paracetamol overdose: a prospective observational study (ATOM-3). Clin Toxicol (Phila) 2018; 56:810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marangos MN, Keroack BJ, Claffey TF. Listeria monocytogenes joint infection in a patient with psoriatic arthritis. J Rheumatol 1996; 23:2005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James LP, Alonso EM, Hynan LS, et al. Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics 2006; 118:e676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James LP, Letzig L, Simpson PM, et al. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos 2009; 37:1779.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 17161 Version 27.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5913083" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Acute liver necrosis following overdose of paracetamol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37552484" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11317062" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Chronic acetaminophen overdosing in children: risk assessment and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9042136" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9469995" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33305966" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1644732" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Acetaminophen overdose as a suicidal gesture: a survey of adolescents' knowledge of its potential for toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2717293" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Parental administration of chemical agents: a cause of apparent life-threatening events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6613961" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Apparent intentional poisoning of an infant with acetaminophen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9640318" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Paediatric exploratory ingestions of paracetamol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10752006" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Acetaminophen intoxication during treatment: what you don't know can hurt you.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3383545" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Death of a child associated with multiple overdoses of acetaminophen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3761116" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Hepatic failure following ingestion of multiple doses of acetaminophen in a young child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8051583" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Parental and medical over-administration of acetaminophen causing lethal hepatotoxicity in a 10-year-old.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10615345" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Childhood hepatotoxicity with paracetamol doses less than 150 mg/kg per day.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8489788" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Is prescribing paracetamol 'pro re nata' acceptable?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10692190" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Prospective evaluation of mild to moderate pediatric acetaminophen exposures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7932911" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Acetaminophen ingestion in childhood--cost and relative risk of alternative referral strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9042116" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Acetaminophen use in children: more is not better.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10615340" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Accidental paracetamol overdosing and fulminant hepatic failure in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29522886" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Medication Errors With Pediatric Liquid Acetaminophen After Standardization of Concentration and Packaging Improvements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9469992" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Acetaminophen overdose with therapeutic intent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9821438" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Combined antipyretic therapy: another potential source of chronic acetaminophen toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22407198" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10768670" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11931497" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : A prospective study of multiple supratherapeutic acetaminophen doses in febrile children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2680215" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Repeated acetaminophen overdosing. Causing hepatotoxicity in children. Clinical reports and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11388672" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21443426" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Intravenous paracetamol--an international perspective of toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22271694" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Intravenous acetaminophen in the United States: iatrogenic dosing errors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7039926" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Clinical pharmacokinetics of paracetamol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8909277" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Late increase in acetaminophen concentration after overdose of Tylenol Extended Relief.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9209234" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Tylenol Extended Relief overdose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8618248" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Pharmacokinetics of extended relief vs regular release Tylenol in simulated human overdose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7914547" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Delayed toxic acetaminophen level after initial four hour nontoxic level.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9286887" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10579478" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2817936" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Paracetamol suppositories: a comparative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8853667" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : A pharmacokinetic comparison of acetaminophen products (Tylenol Extended Relief vs regular Tylenol)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11956504" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11215692" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4417718" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6487352" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Mechanism of action of paracetamol protective agents in mice in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4746326" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4746329" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12890847" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Drug-induced hepatotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1640353" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8812206" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Sex- and age-dependent acetaminophen hepato- and nephrotoxicity in Sprague-Dawley rats: role of tissue accumulation, nonprotein sulfhydryl depletion, and covalent binding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6711498" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Acetaminophen overdose in young children. Treatment and effects of alcohol and other additional ingestants in 417 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/724342" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Acetaminophen overdose: incidence, diagnosis, and management in 416 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1931463" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Paracetamol poisoning in children and hepatotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7469631" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Age as a variable in acetaminophen overdose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1261167" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Acetaminophen elimination kinetics in neonates, children, and adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7359370" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9329933" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Acetaminophen toxicity in an urban county hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7990219" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Association of acetaminophen hepatotoxicity with fasting and ethanol use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2914012" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3827934" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/566490" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Nutrition and the intracellular site of toxic injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9129488" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Inflammatory mediators in children with protein-energy malnutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/109346" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Effect of fasting on metabolite-mediated hepatotoxicity in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12630972" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Glutathione, glutathione-dependent enzymes and antioxidant status in erythrocytes from children treated with high-dose paracetamol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6489428" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Acetaminophen accumulation in pediatric patients after repeated therapeutic doses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8523184" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Fulminant hepatitis associated with centrilobular hepatic necrosis in young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1732127" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8409343" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Gilbert's disease: a risk factor for paracetamol overdosage?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3113968" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6848304" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Acetaminophen in chronic liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/487696" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1354974" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7508362" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1626578" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8659683" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3567011" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Inter-subject and ethnic differences in paracetamol metabolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7658783" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Paracetamol (acetaminophen) poisoning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1683827" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Assessment and treatment of acetaminophen overdose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6343056" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Paracetamol overdosage. Pharmacological considerations and clinical management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7498656" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7498656" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1928874" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/519312" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3059186" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28644687" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16496488" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15459622" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3710497" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Analysis of factors responsible for continuing mortality after paracetamol overdose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/577576" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Liver toxicity after acetaminophen ingestion. Inadequacy of the dose estimate as an index of risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27788602" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Can a serum acetaminophen concentration obtained less than 4 hours post-ingestion determine which patients do not require treatment with acetylcysteine?()
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1134886" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Acetaminophen poisoning and toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23473457" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Treating acetaminophen overdose: thresholds, costs and uncertainties.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8984750" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : [Recommendations for treatment of paracetamol poisoning. Danish Medical Society, Study of the Liver].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8984750" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : [Recommendations for treatment of paracetamol poisoning. Danish Medical Society, Study of the Liver].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29451045" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Modified release paracetamol overdose: a prospective observational study (ATOM-3).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8923390" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Listeria monocytogenes joint infection in a patient with psoriatic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16950959" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19439490" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
